Related Experiment Video
Updated: Jul 25, 2025

A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes
Published on: October 28, 2021
A new method for classifying prognostic risk factors in lung transplant candidates
Carli J Lehr1, Jarrod E Dalton2, Paul R Gunsalus2
1Department of Pulmonary Medicine, Cleveland Clinic, Cleveland, Ohio.
Background:
Predicting risk of waitlist mortality and subsequent classification of lung transplant candidates has been difficult due to inter-relatedness of risk factors, differential risk across populations, and changes in relationships over time. We developed a clinically intuitive indexing system to simplify mortality risk assessment.
Methods:
Scientific Registry of Transplant Recipients data from February 19, 2015, to May 26, 2020 (n = 13,726) were used to estimate 3 constructs. Airway and oxygen function indices were estimated using confirmatory factor analysis and hierarchical clustering was used to derive respiratory support clusters. Cox proportional hazards regression was used to characterize event-free waitlist survival by constructs (3), age, sex, and diagnosis group. Model performance was compared to the Lung Allocation Score/Composite Allocation Score (LAS/CAS).
Results:
Airway and oxygen function indices were created with substantive factor loadings forced expiratory volume (0.86), forced vital capacity (0.64), partial pressure of carbon dioxide (0.56) and PO2/fraction of inspired oxygen (0.83), partial pressure of oxygen (0.59), and mean pulmonary artery pressure (0.30), respectively. Four respiratory support clusters (C1: as needed O2, C2: continuous O2, C3: continuous O2/positive pressure ventilation (PPV), C4: PPV + extracorporeal membrane oxygenation) were identified. Constructs were used to identify patient profiles. Model area under the receiver operating characteristic curve was 0.85 [0.84, 0.87] compared to the LAS 0.92 [0.91, 0.94] at 4 weeks. Risk predictions were relatively insensitive to airway and oxygen function indices in C1 and C4 but varied across C2 and C3.
Conclusions:
Reducing the dimensionality of waitlist mortality risk offers an opportunity to identify clinical phenotypes that are more nuanced and thus more interpretable than current risk assessment provided by the LAS/CAS models.

